ArticleBMC health services research2025

Real world initiation of newly funded empagliflozin and dulaglutide under special authority for patients with type 2 diabetes in New Zealand.

Lynne Chepulis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.